The Good News: The first clinical trial for healing an injured heart by using a subject’s own stem cells is underway. Pfizer proactively and voluntarily halted a trial after results showed it was to likely to be successful.
The Bad News: The validity of clinical trials conducted China is under scrutiny because of too many positive results. A columnist says some trials may be rushed and done poorly to get drugs to market quickly.
All in all, another normal day of mixed news about whether trials are mostly helping or harming. Here’s to hoping that on this July 4 eve we start moving in a direction where there’s more good news than bad news for the American people and the global community.
Doubts Cast On Credibility Of Some Published Clinical Trials – Science Daily (press release) – USA- However, all RCTs of pre-market drug clinical trial were authentic, and RCTs conducted at hospitals affiliated with medical universities were more likely to …